Skip to main content
COAG logo

COAG · Hemab Therapeutics Holdings, Inc.

Track COAG — free
$54.94 +0.99 (+1.84%) At close · Aug 14
Market Cap
$2.57B
Shares
46.71M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
2,113,155 +3.7% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
70/100
Short interest 4.4% of shares — P70 Days to cover 4.3 — P61 Price vs VWAP +43.0% — P99 Short-volume trend -5.2% — P31 Short interest change +22.9% — P86 Worst FTD 0.26% of shares — P87

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 2,038,062 1,658,857 +379,205 4.25
2026-07-15 1,658,857 1,714,796 -55,939 5.33
2026-06-30 1,714,796 1,354,937 +359,859 4.05
2026-06-15 1,354,937 1,026,514 +328,423 7.55
2026-05-29 1,026,514 758,697 +267,817 6.49
2026-05-15 758,697 0 +758,697 1.22
Showing 1–6 of 6 settlements
Key facts CIK 2114044 CUSIP 423494103 13F (30d) 61 filings 57 filers Visit website Investor relations